About Clinical Research
Study #57424
Are You a Good Fit?
- Receive up to $8,000 for your participation in this study
What are the Time Requirements?
Group 4
Visit DatesHow Much: Up to $8,000
Group 5
Visit DatesHow Much: Up to $8,000
Group 6
Visit DatesHow Much: Up to $8,000
BMI Calculator
Referral Program
Do not forget our REFERRAL PROGRAM. Earn at least $200 for every new participant you refer who completes a study.*
*No referral bonuses are paid out for outpatient vaccine studies.
All study dates are tentative and subject to change.
• Male contraception – If capable of producing sperm, the participant agrees to the following during the intervention period and for at least the time needed to eliminate the study intervention after the last dose of study intervention. The length of time required to continue contraception for the study intervention is: 100 days (approximately 14 weeks) after the last dose.
o Abstains from penile-vaginal intercourse as their preferred and usual lifestyle (abstinent on a long-term and persistent basis) and agrees to remain abstinent
OR
o Uses contraception as detailed below unless confirmed to be azoospermic (vasectomized or secondary to medical cause, documented from the site personnel’s review of the participant’s medical records, medical examination, or medical history interview) as detailed below:
Uses a penile/external condom when having penile-vaginal intercourse with a nonparticipant of childbearing potential who is not currently pregnant and should also be advised of the benefit for that partner to use an additional method of contraception, as a condom may break or leak.
Note: Participants capable of producing ejaculate whose partner is pregnant or breastfeeding must agree to use penile/external condom during each episode of sexual activity in which the partner is at risk of drug exposure via ejaculate.
• WOCBP (Women of Child Bearing Potential) – A participant assigned female sex at birth is eligible to participate if not pregnant or breastfeeding, and at least one of the following conditions applies. The length of time required to continue contraception for the study intervention is: 100 days (approximately 14 weeks) after the last dose.
o Documented hysterectomy
o Documented bilateral salpingectomy
o Documented bilateral oophorectomy
o IUS (progestin-releasing IUD)
o Progestogen-only subdermal implant
o Nonhormonal IUD
o Bilateral tubal occlusion/ligation
o Vasectomized partner
o Sexual Abstinence
• WONCBP (Women of Non-Child Bearing Potential)
o A postmenopausal state is defined as no menses for 12 months without an alternative medical cause.
If you have previously submitted an application, call 417-831-2048 to enroll. Or click on the button below to submit your application now.